Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity and capital structure updates.
- Shares Purchased: 1,016,186 ordinary shares
- Purchase Date: June 20, 2025
- Price Range: 382.70p (Low) to 388.00p (High)
- Volume Weighted Average Price: 385.10p
- Registered Share Capital: 8,991,557,409 ordinary shares of £0.01 each
- Treasury Shares: 4,080,205
- Voting Shares: 8,987,477,204
Material Changes
Following the settlement of the June 20, 2025 transaction, the Company's share count has been reduced. The number of ordinary shares with voting rights is now 8,987,477,204. This figure is the basis for shareholders to determine notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction. The announcement explicitly states it does not constitute an offer or solicitation of an offer for securities.
Investor Verification Checklist
- Verify the total number of shares repurchased to date under the March 28, 2025 Buyback Programme.
- Confirm the current market price of Haleon shares relative to the 385.10p average purchase price.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction data.
- Check subsequent filings for updates on the remaining authorization for the share buyback programme.